Harrow Stock (NASDAQ: HROW) stock price, news, charts, stock research, profile.
Open | $45.36 |
Close | - |
Volume / Avg. | 121.62K / 569.64K |
Day Range | $44.00 - $46.02 |
52 Wk Range | 7.60 - 47.55 |
Market Cap | $1.58B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 16.37% |
Days to Cover | 6.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Harrow (NASDAQ:HROW) through any online brokerage.
Other companies in Harrow’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Neumora Therapeutics (NASDAQ:NMRA).
Harrow has a consensus price target of $36.00.
The stock price for Harrow (NASDAQ: HROW) is $44.57 last updated September 23, 2024 at 12:57 PM EDT.
There are no upcoming dividends for Harrow.
Harrow’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Harrow.
Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.